Myriad Genetics, Inc. recently announced that it has launched myRisk Hereditary Cancer, a new multi-gene diagnostic test that will provide increased sensitivity by analyzing 25 genes associated with eight major cancers including breast, colorectal, ovarian, endometrial, pancreatic, prostate, gastric and melanoma cancer.
Want to read more?
Subscribe to one of our monthly plans to continue reading this article.